Albert Y Lin

Summary

Affiliation: Santa Clara Valley Medical Center
Country: USA

Publications

  1. ncbi request reprint Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma
    Albert Y Lin
    Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128, USA
    Cancer 103:119-25. 2005
  2. doi request reprint Phase II study of imatinib in unresectable hepatocellular carcinoma
    Albert Y Lin
    Department of Medicine, Santa Clara Valley Medical Center, 751 S Bascom Avenue, San Jose, CA 95128, USA
    Am J Clin Oncol 31:84-8. 2008
  3. doi request reprint Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis
    An Ting T Lu
    Santa Clara Valley Medical Center, San Jose, CA 95128, USA
    Clin Colorectal Cancer 8:207-14. 2009
  4. doi request reprint Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer
    Natalia B Kouzminova
    Department of Hematology Oncology, Santa Clara Valley Medical Center, Santa Clara, CA, USA
    Am J Surg 198:771-80. 2009

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma
    Albert Y Lin
    Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128, USA
    Cancer 103:119-25. 2005
    ..Therefore, the authors initiated a study to assess the efficacy and toxicity of thalidomide in patients with advanced HCC as primary and secondary endpoints, respectively...
  2. doi request reprint Phase II study of imatinib in unresectable hepatocellular carcinoma
    Albert Y Lin
    Department of Medicine, Santa Clara Valley Medical Center, 751 S Bascom Avenue, San Jose, CA 95128, USA
    Am J Clin Oncol 31:84-8. 2008
    ..Imatinib, a potent inhibitor of BCR-ABL and c-kit, also inhibits the platelet-derived growth factor receptor tyrosine kinase. The trial was designed to assess the efficacy and safety of imatinib in patients with unresectable HCC...
  3. doi request reprint Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis
    An Ting T Lu
    Santa Clara Valley Medical Center, San Jose, CA 95128, USA
    Clin Colorectal Cancer 8:207-14. 2009
    ..We performed a systematic review and meta-analysis of gene expression profiles (GEPs) to assess their utility for risk stratification and prediction of poor outcomes in stage II CRC...
  4. doi request reprint Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer
    Natalia B Kouzminova
    Department of Hematology Oncology, Santa Clara Valley Medical Center, Santa Clara, CA, USA
    Am J Surg 198:771-80. 2009
    ..The aim of this study was to assess the impact of initial margins and residual carcinoma found on second surgery on the outcomes of breast cancer patients...